Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Adenocarcinoma of the Colon|Adenocarcinoma of the Gallbladder|Adenocarcinoma of the Pancreas|Adenocarcinoma of the Rectum|Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Cholangiocarcinoma of the Gallbladder|Diffuse Adenocarcinoma of the Stomach|Intestinal Adenocarcinoma of the Stomach|Male Breast Cancer|Mixed Adenocarcinoma of the Stomach|Ovarian Endometrioid Adenocarcinoma|Paget Disease of the Breast With Intraductal Carcinoma|Paget Disease of the Breast With Invasive Ductal Carcinoma|Recurrent Adult Primary Liver Cancer|Recurrent Breast Cancer|Recurrent Colon Cancer|Recurrent Gallbladder Cancer|Recurrent Gastric Cancer|Recurrent Malignant Testicular Germ Cell Tumor|Recurrent Pancreatic Cancer|Recurrent Rectal Cancer|Recurrent Salivary Gland Cancer|Salivary Gland Adenocarcinoma|Stage II Malignant Testicular Germ Cell Tumor|Stage II Pancreatic Cancer|Stage III Colon Cancer|Stage III Gastric Cancer|Stage III Malignant Testicular Germ Cell Tumor|Stage III Pancreatic Cancer|Stage III Rectal Cancer|Stage III Salivary Gland Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer|Stage IV Colon Cancer|Stage IV Gastric Cancer|Stage IV Pancreatic Cancer|Stage IV Rectal Cancer|Stage IV Salivary Gland Cancer|Thyroid Gland Medullary Carcinoma|Unresectable Gallbladder Cancer
Interventions: BIOLOGICAL: recombinant fowlpox-CEA(6D)/TRICOM vaccine|BIOLOGICAL: sargramostim|BIOLOGICAL: recombinant fowlpox GM-CSF vaccine adjuvant
Sponsor: National Cancer Institute (NCI)